Analysis for the premature treatment termination and treatment readmission process.</p
<p>Interrupted time series analyses results, reporting immediate changes in treatment of cardiovascu...
<p>Summary of sequential lines of treatment, therapy responses and mutation status.</p
Analysis of descriptive variables in relation with attrition and experimental condition.</p
Cumulative incidence of premature treatment termination and readmission by group.</p
Analyses for primary outcome (readmission to hospital) and secondary outcome (all-cause mortality).<...
Response and remission rates at each assessment point after randomization by treatment condition.</p
<p>Enrollment, randomization, withdrawals, and completion of the 2 treatment phases (n = 11).</p
<p>Logistic regression analysis for the treatment need at the end of the follow-up period (T<sub>1</...
Medications and devices applied during follow-up, after treatment optimization.</p
<p>Kaplan-Meier plot of time to early discontinuation of initial randomized treatment for any reason...
Continuous time-to-completion functional analysis of length of chemotherapy regimen and survival.</p
Predefined clinical subgroup analysis with expulsion time comparing silodosin with tamsulosin.</p
Readiness lost in the monitor-modify therapy stage: Estimates with & without emergency protocols.</p
<p>Probabilistic sensitivity analysis frequency and cumulative frequency of cost of cessation treatm...
Showing the number of patients discontinuing therapy and the primary documented causes by drug group...
<p>Interrupted time series analyses results, reporting immediate changes in treatment of cardiovascu...
<p>Summary of sequential lines of treatment, therapy responses and mutation status.</p
Analysis of descriptive variables in relation with attrition and experimental condition.</p
Cumulative incidence of premature treatment termination and readmission by group.</p
Analyses for primary outcome (readmission to hospital) and secondary outcome (all-cause mortality).<...
Response and remission rates at each assessment point after randomization by treatment condition.</p
<p>Enrollment, randomization, withdrawals, and completion of the 2 treatment phases (n = 11).</p
<p>Logistic regression analysis for the treatment need at the end of the follow-up period (T<sub>1</...
Medications and devices applied during follow-up, after treatment optimization.</p
<p>Kaplan-Meier plot of time to early discontinuation of initial randomized treatment for any reason...
Continuous time-to-completion functional analysis of length of chemotherapy regimen and survival.</p
Predefined clinical subgroup analysis with expulsion time comparing silodosin with tamsulosin.</p
Readiness lost in the monitor-modify therapy stage: Estimates with & without emergency protocols.</p
<p>Probabilistic sensitivity analysis frequency and cumulative frequency of cost of cessation treatm...
Showing the number of patients discontinuing therapy and the primary documented causes by drug group...
<p>Interrupted time series analyses results, reporting immediate changes in treatment of cardiovascu...
<p>Summary of sequential lines of treatment, therapy responses and mutation status.</p
Analysis of descriptive variables in relation with attrition and experimental condition.</p
DOI
Add to ORKG